Evidence map›Paper›PMID 38465284›Full record

ArticleJACC. Case reports2024

Coexistence of Light Chain and Transthyretin Cardiac Amyloidosis.

Abhishek Gami, John Woller, Paul Scheel, Syed Abbas Ali, Carol Ann Huff, Charles Steenbergen, Marc Halushka, Kavita Sharma, Michael Polydefkis, Joban Vaishnav

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in JACC. Case reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Abhishek GamiDepartment of Internal Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
John WollerDepartment of Internal Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Paul ScheelDivision of Cardiology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Syed Abbas AliDepartment of Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Carol Ann HuffDepartment of Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Charles SteenbergenDepartment of Cardiovascular Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Marc HalushkaPathology and Laboratory Medicine Institute, Cleveland Clinic, Cleveland, Ohio, USA.
Kavita SharmaDivision of Cardiology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Michael PolydefkisDepartment of Neurology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Joban VaishnavDivision of Cardiology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Although most patients with cardiac amyloidosis are diagnosed with either light chain (AL) or transthyretin (ATTR) disease, coexisting amyloid subtypes can occur. We present three cases of coexisting AL and ATTR cardiac amyloidosis and demonstrate the importance of clinical history and endomyocardial biopsy in diagnosis of this rare entity.

Indexed as

cardiac amyloidosisendomyocardial biopsylight chaintransthyretin

Identifiers

PMID38465284
PMCPMC10918558

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.